Article Information
History
- May 8, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Philip M. Carlucci1,
- Tania Ahuja2,
- Christopher Petrilli1,3,
- Harish Rajagopalan3,
- Simon Jones4,5 and
- Joseph Rahimian1,*
- 1New York University Grossman School of Medicine, Department of Medicine, New York, NY
- 2New York University Langone Health, Department of Pharmacy, New York, NY
- 3NYU Langone Health, New York, NY
- 4Division of Healthcare Delivery Science, Department of Population Health, NYU Grossman School of Medicine, New York, NY
- 5Center for Healthcare Innovation and Delivery Science, NYU Langone Health, New York, NY
- 6Division of Infectious Diseases and Immunology, Department of Medicine, NYU Grossman School of Medicine, New York, NY
- ↵*Corresponding author: Joseph Rahimian, MD, NYU Grossman School of Medicine, Department of Medicine 31 Washington Square West, Floor number 4, New York, NY 10011, Joseph.Rahimian{at}nyulangone.org, (212) 465-8834
Posted May 08, 2020.
Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients
Subject Area
Reviews and Context
50
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
44
Blogs/Media
Author Videos